U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Anti-HIV Agents [Pharmacological Action]

Tree Number(s): D019380

MeSH Unique ID: D019380

  • azodicarbonamide (Supplementary Concept)
  • ubenimex (Supplementary Concept)
  • aminomethyltrioxsalen (Supplementary Concept)
  • murabutide (Supplementary Concept)
  • zidovudine triphosphate (Supplementary Concept)
  • carbovir (Supplementary Concept)
  • pradimicin A (Supplementary Concept)
  • miglustat (Supplementary Concept)
  • 1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine (Supplementary Concept)
  • lobucavir (Supplementary Concept)
  • R-82913 (Supplementary Concept)
  • N-gamma-glutamylcysteine ethyl ester (Supplementary Concept)
  • virion host shutoff protein, Simplexvirus (Supplementary Concept)
  • troxacitabine (Supplementary Concept)
  • TSAO-T (Supplementary Concept)
  • 2'3'-didehydro-2'3'-dideoxyadenosine (Supplementary Concept)
  • calanolide A (Supplementary Concept)
  • recombinant soluble CD4 (Supplementary Concept)
  • viscum album peptide (Supplementary Concept)
  • kynostatin 272 (Supplementary Concept)
  • GEM91 (Supplementary Concept)
  • aldesleukin (Supplementary Concept)
  • cosalane (Supplementary Concept)
  • plerixafor (Supplementary Concept)
  • amprenavir (Supplementary Concept)
  • dexelvucitabine (Supplementary Concept)
  • abacavir (Supplementary Concept)
  • tipranavir (Supplementary Concept)
  • vMIP-II (Supplementary Concept)
  • lamivudine, zidovudine drug combination (Supplementary Concept)
  • fosamprenavir (Supplementary Concept)
  • capravirine (Supplementary Concept)
  • 3'-deoxycytidine (Supplementary Concept)
  • ibalizumab (Supplementary Concept)
  • Dapivirine (Supplementary Concept)
  • elvitegravir (Supplementary Concept)
  • stavudine, lamivudine, nevirapine drug combination (Supplementary Concept)
  • GS-9131 (Supplementary Concept)
  • hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine (Supplementary Concept)
  • fostemsavir (Supplementary Concept)
  • emtricitabine tenofovir alafenamide (Supplementary Concept)
  • BMS-955176 (Supplementary Concept)
  • XZ460 (Supplementary Concept)
  • XZ456 (Supplementary Concept)
  • XZ462 (Supplementary Concept)
  • GSK-2838232 (Supplementary Concept)
  • dolutegravir, rilpivirine drug combination (Supplementary Concept)
  • efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
  • lamivudine, tenofovir disoproxil fumarate drug combination (Supplementary Concept)
  • abacavir, dolutegravir, and lamivudine drug combination (Supplementary Concept)
  • cobicistat mixture with darunavir (Supplementary Concept)
  • cabotegravir, rilpivirine drug combination (Supplementary Concept)
  • elsulfavirine (Supplementary Concept)
  • Zidovudine (MeSH Term)
  • Trichosanthin (MeSH Term)
  • Zalcitabine (MeSH Term)
  • Didanosine (MeSH Term)
  • Stavudine (MeSH Term)
  • Lamivudine (MeSH Term)
  • Nevirapine (MeSH Term)
  • Delavirdine (MeSH Term)
  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Emtricitabine, Rilpivirine, Tenofovir Drug Combination (MeSH Term)
  • Emtricitabine (MeSH Term)
  • Rilpivirine (MeSH Term)
  • Tenofovir (MeSH Term)
  • Raltegravir Potassium (MeSH Term)
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (MeSH Term)
  • Cobicistat (MeSH Term)
  • UK 457,758 (Supplementary Concept)
  • cenicriviroc (Supplementary Concept)
  • TAK 779 (Supplementary Concept)
  • AD 101 (Supplementary Concept)
  • PF 232798 (Supplementary Concept)
  • CMPD 167 (Supplementary Concept)
  • N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide (Supplementary Concept)
  • N-(3-isopropyl-3-((4-(4-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)carbonyl)cyclopentyl)-3-methoxytetrahydro-2H-pyran-4-amine (Supplementary Concept)
  • GSK 163929 (Supplementary Concept)
  • 4-(4-((1-butyl-3-(cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro(5.5)undec-9-yl)methyl)phenoxy)benzoic acid (Supplementary Concept)
  • nifeviroc (Supplementary Concept)
  • TD-0680 (Supplementary Concept)
  • RO-5657 (Supplementary Concept)
  • Ancriviroc (Supplementary Concept)
  • (4,6-dimethyl-1-oxypyrimidin-5-yl)(4-diphenylamino-4'-methyl-(1,4')bipiperidinyl-1'-yl)methanone (Supplementary Concept)
  • RANTES, N(alpha)-(n-nonanoyl)-desSer(1)-(thioproline(2),cyclohexylglycine(3))- (Supplementary Concept)
  • 1-(3-aminopropyl) piperazine-4-aminoamide (Supplementary Concept)
  • BMS-488043 (Supplementary Concept)
  • leronlimab (Supplementary Concept)
  • aplaviroc (Supplementary Concept)
  • phenyl-1H-pyrrole-carboxamide (Supplementary Concept)
  • 3,5-dicaffeoylquinic acid (Supplementary Concept)
  • chicoric acid (Supplementary Concept)
  • aspochalasin L (Supplementary Concept)
  • dolutegravir (Supplementary Concept)
  • EBR28 peptide (Supplementary Concept)
  • BMS-707035 (Supplementary Concept)
  • 7-(3,4-dichlorobenzyl)-5,9-dihydroxypyrrolo(3,4-g)quinoxaline-6,8-dione (Supplementary Concept)
  • 7-(4-chlorobenzyl)-5,9-dihydroxypyrrolo(3,4-g)quinoxaline-6,8-dione (Supplementary Concept)
  • cabotegravir (Supplementary Concept)
  • MUT-A compound (Supplementary Concept)
  • INRAT10b (Supplementary Concept)
  • DMP 323 (Supplementary Concept)
  • Abbott 77003 (Supplementary Concept)
  • tetrahydrofuranylcarbamatemonopyrrolinone (Supplementary Concept)
  • hinnuliquinone (Supplementary Concept)
  • N-(2''-hydroxy-2''-(4-hydroxy-16-oxo-7,8,9,10,11,12,13,14,15,16-decahydro-6H-5-oxa-15-azabenzocyclotetradecen-14-yl)ethyl)-N-isobutyl-4-methoxybenzenesulfonamide (Supplementary Concept)
  • Maraviroc (MeSH Term)
  • Enfuvirtide (MeSH Term)
  • Atazanavir Sulfate (MeSH Term)
  • Darunavir (MeSH Term)
  • Saquinavir (MeSH Term)
  • Ritonavir (MeSH Term)
  • Indinavir (MeSH Term)
  • Nelfinavir (MeSH Term)
  • Lopinavir (MeSH Term)

Supplemental Content

Loading ...